Abstract
Abstract
A 23-subject feasibility study is reported to assess how UV absorbance measurements on exhaled breath samples collected from silicon microreactors can be used to detect COVID-19. The silicon microreactor technology chemoselectively preconcentrates exhaled carbonyl volatile organic compounds and subsequent methanol elution provides samples for analysis. The underlying scientific rationale that viral infection will induce an increase in exhaled carbonyls appears to be supported by the results of the feasibility study. The data indicate statistically significant differences in measured UV absorbance values between healthy and symptomatic COVID-19 positive subjects in the wavelength range from 235 nm to 305 nm. Factors such as subject age were noted as potential confounding variables.
Funder
Gilead Sciences
National Institute of Environmental Health Sciences
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Institute of Allergy and Infectious Diseases
Subject
Pulmonary and Respiratory Medicine
Reference46 articles.
1. SARS-CoV-2 pathogenesis;Lamers;Nat. Rev. Microbiol.,2022
2. Everyone included: social impact of COVID-19
3. Analysis of exhaled breath for disease detection;Amann;Ann. Rev. Anal. Chem.,2014
4. Human exhaled air analytics: biomarkers of diseases;Buszewski;Biomed. Chromatogr.,2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献